4,716 Shares in HCA Healthcare, Inc. $HCA Acquired by WBI Investments LLC

WBI Investments LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 4,716 shares of the company’s stock, valued at approximately $1,629,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HCA. Geneos Wealth Management Inc. boosted its holdings in shares of HCA Healthcare by 6.1% during the 1st quarter. Geneos Wealth Management Inc. now owns 3,510 shares of the company’s stock valued at $1,213,000 after acquiring an additional 201 shares during the last quarter. Belpointe Asset Management LLC purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at about $767,000. Fortis Capital Advisors LLC purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at about $767,000. Focus Partners Wealth boosted its holdings in shares of HCA Healthcare by 4.8% during the 1st quarter. Focus Partners Wealth now owns 6,617 shares of the company’s stock valued at $2,287,000 after acquiring an additional 301 shares during the last quarter. Finally, Anchor Investment Management LLC boosted its holdings in shares of HCA Healthcare by 2,162.2% during the 1st quarter. Anchor Investment Management LLC now owns 837 shares of the company’s stock valued at $289,000 after acquiring an additional 800 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have weighed in on HCA. Bank of America increased their target price on HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a report on Wednesday. Stephens raised HCA Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Royal Bank Of Canada decreased their price objective on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a research note on Monday, July 28th. Wolfe Research downgraded HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $444.00 price objective on shares of HCA Healthcare in a research note on Tuesday, August 26th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $403.17.

HCA Healthcare Stock Down 4.7%

Shares of HCA opened at $394.00 on Thursday. The business’s 50 day moving average is $381.63 and its 200 day moving average is $361.70. The company has a market capitalization of $92.19 billion, a PE ratio of 16.56, a price-to-earnings-growth ratio of 1.30 and a beta of 1.41. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $420.98. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the company earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.30% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.